Cancers | Top 10 Cited Papers in 2020 in the Section “Cancer Drug Development”

We are pleased to invite you to read the top 10 cited papers in 2020 in Cancers (ISSN: 2072-6694) in the Section "Cancer Drug Development". The paper list is as follows:

1. “Cannabidiol (CBD) as a Promising Anti-Cancer Drug”
by Emily S. Seltzer, Andrea K. Watters, Danny MacKenzie, Jr., Lauren M. Granat and Dong Zhang
Cancers 2020, 12(11), 3203; https://doi.org/10.3390/cancers12113203
Available online: https://www.mdpi.com/2072-6694/12/11/3203

2. “Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines”
by Wei Guo, Hor-Yue Tan, Feiyu Chen, Ning Wang and Yibin Feng
Cancers 2020, 12(2), 404; https://doi.org/10.3390/cancers12020404
Available online: https://www.mdpi.com/2072-6694/12/2/404

3. “Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs”
by Chung-Pu Wu, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Tai-Ho Hung and Yu-Shan Wu
Cancers 2020, 12(1), 195; https://doi.org/10.3390/cancers12010195
Available online: https://www.mdpi.com/2072-6694/12/1/195

4. “Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma”
by Dominika Fassmannová, František Sedlák, Jindřich Sedláček, Ivan Špička and Klára Grantz Šašková
Cancers 2020, 12(5), 1065; https://doi.org/10.3390/cancers12051065
Available online: https://www.mdpi.com/2072-6694/12/5/1065

5. “Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs”
by Chung-Pu Wu, Tai-Ho Hung, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Shun-Ping Wang and Yu-Shan Wu
Cancers 2020, 12(6), 1366; https://doi.org/10.3390/cancers12061366
Available online: https://www.mdpi.com/2072-6694/12/6/1366

6. “Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer”
by Filippos Koinis, Paul Corn, Nila Parikh, Jian Song, Ioulia Vardaki, Ioanna Mourkioti, Sue-Hwa Lin, Christopher Logothetis, Theocharis Panaretakis and Gary Gallick
Cancers 2020, 12(1), 244; https://doi.org/10.3390/cancers12010244
Available online: https://www.mdpi.com/2072-6694/12/1/244

7. “Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1”
by Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz and Matthias U. Kassack
Cancers 2020, 12(2), 337; https://doi.org/10.3390/cancers12020337
Available online: https://www.mdpi.com/2072-6694/12/2/337

8. “Mambalgin-2 Induces Cell Cycle Arrest and Apoptosis in Glioma Cells via Interaction with ASIC1a”
by Maxim Bychkov, Mikhail Shulepko, Dmitry Osmakov, Yaroslav Andreev, Anastasia Sudarikova, Valeria Vasileva, Marat S. Pavlyukov, Yaroslav A. Latyshev, Alexander A. Potapov, Mikhail Kirpichnikov et al.
Cancers 2020, 12(7), 1837; https://doi.org/10.3390/cancers12071837
Available online: https://www.mdpi.com/2072-6694/12/7/1837

9. “Electroporation-Based Treatments in Urology”
by Aleksander Kiełbik, Wojciech Szlasa, Jolanta Saczko and Julita Kulbacka
Cancers 2020, 12(8), 2208; https://doi.org/10.3390/cancers12082208
Available online: https://www.mdpi.com/2072-6694/12/8/2208

10. “L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs”
by Małgorzata Krzystek-Korpacka, Berenika Szczęśniak-Sięga, Izabela Szczuka, Paulina Fortuna, Marek Zawadzki, Agnieszka Kubiak, Magdalena Mierzchała-Pasierb, Mariusz G. Fleszar, Łukasz Lewandowski, Paweł Serek et al.
Cancers 2020, 12(9), 2594; https://doi.org/10.3390/cancers12092594
Available online: https://www.mdpi.com/2072-6694/12/9/2594